Published Date : May 14, 2018
ALBANY, New York, May 14, 2018 –MarketResearchReports.biz has announced the addition of a new report titled “Porcine Vaccines Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017–2025”. The in-depth study on the global porcine vaccines market presents insights on key trends and developments, major technological advancements, lucrative product segments, and the prevailing competitive landscape in various regions. The global porcine vaccines market is projected to reach a worth of US$ 3,208.8 Mn by 2025 end. The market is estimated to rise at a CAGR of over 7.0% during the forecast period of 2017–2025. The global porcine vaccines market is driven primarily by the rising incidence of swine diseases assuming the proportion of zoonotic threat in various parts of the world.
The growing prevalence of viral and bacterial pathogens affecting swine herds is a notable factor accentuating the growth of the porcine vaccines market. Intensive efforts by government is several emerging and developed economies to eradicate infectious agents causing swine flu is also bolstering the demand for porcine vaccines.
The substantial demand for pork and gelatin from pigs in several countries of the globe is a notable factor accentuating the market. The demand for porcine vaccines is also benefitting from the bold strides taken by the livestock industry. The substantial spending by farm owners in maintaining the upkeep of health of swine is also boosting the market.
For Sample Copy, click here: https://www.marketresearchreports.biz/sample/sample/1753274
The market has also benefited from the marked success of porcine vaccines, thereby accentuating the demand for booster dosage. The vast technological advances made in recent years has resulted in the market gaining immense traction in recent years. In this regard, the advent of porcine vaccines with value-added features is a crucial trend catalyzing the growth of the market.
Sizeable fund being committed to the development of more efficacious drugs for porcine reproductive and respiratory syndrome virus (PRRSV) augurs well for the market. The growing popularity of accentuated vaccines in this regard is providing robust impetus tie demand for porcine vaccines. However, the product is likely to lose some share to DNA vaccines. The wide popularity of DNA-based porcine vaccines across veterinary hospitals and hog production farms stems from the several advantages these have.
Regionally, North America held the leading share of the global market in 2016 and is anticipated to hold its sway throughout the forecast period. The growth will be supported by a rapid rise in contract and independent farming.
Top players are launching diversified product portfolio and making strategic collaborations, in a move to stay ahead of their competitors. Several prominent players are investing profusely in clinching acquisition deals and are expanding their geographic presence, in order to consolidate their positions in the market.
Some of the key players operating in the global porcine vaccines market are Zoetis, Inc., Bayer AG, Vetoquinol, Bimeda Animal Health, Merck & Co., Inc., Elanco (Eli Lilly and Company), Ceva Santé Animale, and Boehringer Ingelheim GmbH.
To order report Call Toll Free: 866-997-4948 or send an email on email@example.com